Unity Biotechnology, Inc. (UBX) financial statements (2020 and earlier)

Company profile

Business Address 3280 BAYSHORE BOULEVARD
BRISBANE, CA 94005
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments127171
Cash and cash equivalents3715
Short-term investments90156
Other undisclosed current assets22
Total current assets:129173
Noncurrent Assets
Property, plant and equipment176
Long-term investments and receivables3 
Long-term investments3 
Restricted cash and investments11
Other noncurrent assets12
Total noncurrent assets:228
TOTAL ASSETS:151181
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:55
Accounts payable55
Accrued liabilities55
Employee-related liabilities64
Settlement liabilities 2
Other undisclosed accounts payable and accrued liabilities(11)(11)
Other undisclosed current liabilities1212
Total current liabilities:1717
Noncurrent Liabilities
Liabilities, other than long-term debt133
Deferred rent credit132
Other liabilities 0
Other undisclosed noncurrent liabilities 2
Total noncurrent liabilities:134
Total liabilities:3121
Stockholders' equity
Stockholders' equity attributable to parent, including:121161
Common stock00
Additional paid in capital367325
Accumulated other comprehensive income (loss)0(0)
Accumulated deficit(245)(163)
Other undisclosed stockholders' equity attributable to parent(1)(1)
Total stockholders' equity:121161
TOTAL LIABILITIES AND EQUITY:151181

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Operating expenses(90)(79)
Operating loss:(90)(79)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
4(0)
Net loss:(85)(80)
Other undisclosed net income attributable to parent33
Net loss available to common stockholders, diluted:(82)(76)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(85)(80)
Comprehensive loss:(85)(80)
Other undisclosed comprehensive income, net of tax, attributable to parent33
Comprehensive loss, net of tax, attributable to parent:(82)(76)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: